Complementary Therapies in Inflammatory Bowel Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|11|1079-1088

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.11, 2014-10, pp. : 1079-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1107-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Current Biological Therapies for Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4127-4147

Bentham Science Publishers

Access to resources Recommend Favorite

Probiotics and Immune Regulation of Inflammatory Bowel Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory bowel diseases: a new wave of therapy

By Murthy S.   Flanigan A.   Osborne B.J.   Murthy N.S.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 785-818

Informa Healthcare

Access to resources Recommend Favorite

Biologic and Novel Therapy of the Inflammatory Bowel Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite